The only real news close to come would be first patient dosed opening the CD17 CAR-T trial. But using IMU's trials as a guide it will take 18-24 months to get a ph1 safety and maybe some signal read out.
GBM and AML by end '24 or early '25. That's why it is unlikely the sp will rise as the market gave a damn about it so far despite the stunning results. And Hopper's 800m share CR is designed to secure funds to get to '25. But at most likely 2c or less, what will he get, $ 16-20m at best. Not enough at all and another sp decline and 100% dilution. He is " Mr HUGE DISCOUNT " and he hasn't changed his attitude. Baker at RAD showed him how it's done at ALA and got fired. Now you guys get the picture.
Not sure how this can end well, but selling out tomorrow would drive sp to 0.1c and that's the very last resort for me.
GLTA
CHM Price at posting:
2.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)